XL019

SynDRA canonical compound SYN1269737 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	JAK1 \| JAK2 \| JAK3
Mechanism of action	JAK inhibitor

All known targets

JAK1
JAK2
JAK3

Mechanisms of action (all sources)

JAK inhibitor

Cross-references

PubChem CID: 57991377
ChEMBL: CHEMBL2208034
PDB: O19

Synonyms

SCHEMBL4380116
BDBM50402409
AKOS037643412
AS-16325
O19
(2R)-N-[4-[2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl]phenyl]pyrrolidine-2-carboxamide

Look up XL019 in the interactive SynDRA portal →